- Home
- SSSS vs ARCT Comparison
SSSS vs ARCT Comparison
Compare SSSS & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSSS | ARCT |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 189.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | SSSS | ARCT |
|---|---|---|
| Price | $12.05 | $8.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $14.17 | ★ $27.70 |
| AVG Volume (30 Days) | 338.5K | ★ 508.0K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 8.53% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $42.86 | N/A |
| P/E Ratio | $3.61 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.33 | $5.85 |
| 52 Week High | $11.92 | $24.14 |
Technical Indicators
Market Signals| Indicator | SSSS | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 69.28 | 64.93 |
| Support Level | $8.63 | $6.90 |
| Resistance Level | N/A | $8.65 |
| Average True Range (ATR) | 0.56 | 0.47 |
| MACD | 0.18 | 0.20 |
| Stochastic Oscillator | 94.18 | 73.88 |
Price Performance
Historical ComparisonAbout SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.